Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. IRT
7. QCOM
8. ASO
9. LAES
10. NTHI

Go back to Ocular Therapeutix™ Reports Fourth Quarter and Year End 2017 Financial Results and Business Update

Ocular Therapeutix (OCUL) PT Raised to $22 at Cantor Fitzgerald; 'Preparing for a Momentous 2018'

March 8, 2018 10:42 AM EST

Cantor Fitzgerald analyst Elemer Piros raised his price target on Ocular Therapeutix (NASDAQ: OCUL) to $22.00 (from $21.00) while maintaining a Overweight rating, saying the company is preparing for a 'momentous 2018'.

Piros commented, "Ocular hosted a conference call to review its quarterly progress and... More